Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. méd. Chile ; 146(7): 839-845, jul. 2018. tab
Artículo en Español | LILACS | ID: biblio-961469

RESUMEN

Background: Bacteremic pneumococcal pneumonia (BPP) is a preventable disease with high morbimortality. Aim: To evaluate clinical aspects and mortality on BPP patients admitted to a Chilean regional hospital. Patients and Methods: We looked for adult patients with Streptococcus pneumoniae isolated from blood cultures between 2010 and 2014 years and reviewed clinical records of those who were admitted with pneumonia. Results: We identified 70 BPP patients: 58% were men, mean age was 56 years, 30% were > 65 years, 70% with basic public health insurance, 26% were alcoholics, 86% had comorbidities. Only two patients were vaccinated against S. pneumoniae. CURB-65 severity index for community acquired pneumonia was > 3 in 37% of patients. Twenty-four patients were admitted to ICU, twenty required mechanical ventilation and twenty-four died (34%). Mortality was associated with an age over 65 years, presence of comorbidities and complications of pneumonia. A total of 22 serotypes of S. pneumoniae were identified, five of them (1,3,7F,14 y 9V) were present in 57% of cases. Conclusions: Elevated mortality of our BNN patients was associated with comorbidities and possibly with socio economic factors, which conditioned a late access to medical care.


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Neumonía Neumocócica/mortalidad , Bacteriemia/mortalidad , Neumonía Neumocócica/diagnóstico , Neumonía Neumocócica/microbiología , Neumonía Neumocócica/tratamiento farmacológico , Factores Socioeconómicos , Streptococcus pneumoniae/aislamiento & purificación , Índice de Severidad de la Enfermedad , Ceftriaxona/uso terapéutico , Comorbilidad , Chile/epidemiología , Factores de Riesgo , Mortalidad Hospitalaria , Bacteriemia/microbiología , Bacteriemia/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/microbiología , Infecciones Comunitarias Adquiridas/mortalidad , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Antibacterianos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA